On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...